Welcome to the international HTA database

Showing [23371 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Agency for Healthcare Research and Quality (AHRQ)	Childhood obesity prevention programs: comparative effectiveness review and meta-analysis
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Intravenous or rectal acetaminophen for post-operative pain
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ceftaroline fosamil (Zinforo®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Heating standards for magnetic resonance conditional medical devices: clinical evidence
2013	HAYES, Inc.	Platelet function assays for patients on antiplatelet therapy undergoing cardiac surgery
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Plasma vaporization for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Disinfecting caps and antimicrobial locks for reducing blood stream infections associated with central venous catheters
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ingenol mebutate (Picato®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013	HAYES, Inc.	Prophylactic oophorectomy for the prevention of ovarian cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of surgical masks in the operating room: a review of the clinical effectiveness and guidelines
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Relationship between hemoglobin A1c levels and complications after elective hip and knee surgery
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Darunavir (Prezista®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	GreenLight laser for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013	HAYES, Inc.	Pyrocarbon proximal interphalangeal and metacarpophalangeal joint implants
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cleansing of the cervix prior to hysterosalpingogram: clinical evidence and guidelines
2013	NIHR Health Technology Assessment programme	Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisal
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Esophageal temperature measurement to prevent complications of catheter ablation
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ferumoxytol (Rienso®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Community-based programs to improve early childhood health outcomes: guidelines and recommendations
2013	HAYES, Inc.	Risk-reducing (prophylactic) mastectomy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	CPAP treatment for adults with obstructive sleep apnea: review of the clinical and cost-effectiveness and guidelines
2013	NIHR Health Technology Assessment programme	The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Hourly rounding and other interventions to improve patient satisfaction associated with responsiveness
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Lapatinib (Tyverb®)
2013	NIHR Health Technology Assessment programme	Does short cycle antiretroviral therapy impact on inflammation, immune activation, thrombogenesis and CD4 cell dynamics?
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-steroidal anti-inflammatory drugs for pain: comparative clinical and cost-effectiveness
2013	HAYES, Inc.	Transanal hemorrhoidal dearterialization
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dressing materials for the treatment of pressure ulcers in patients in long-term care facilities: a review of the comparative clinical effectiveness and guidelines
2013	Malaysian Health Technology Assessment (MaHTAS)	X Collar versus conventional cervical collar
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Securement devices for peripherally inserted central venous catheters (PICCs) and Midline catheters
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ulipristal acetate (Esmya®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of chronic obstructive pulmonary disease in primary and community care: guidelines
2013	HAYES, Inc.	Transcatheter aortic valve implantation for aortic stenosis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone versus methadone for the treatment of opioid dependence: a review of the clinical and cost-effectiveness
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Adalimumab (Humira®)
2013	HAYES, Inc.	Trigger point injections for myofascial pain
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Comparison of the Ankle Brachial Pressure Index (ABI) doppler with the pocket doppler with plethysmography probe in the assessment of arterial disease in diabetic patients: clinical and cost-effectiveness
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tenofovir disoproxil fumarate (Viread®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal in-hospital umbilical cord care for newborns: clinical evidence and guidelines
2013	HAYES, Inc.	Umbilical cord blood stem cell transplantation for hematological and lymphoid malignancies in adults
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Medication administration via metered dose inhalers and aerochambers versus nebulizers for adult patients: clinical effectiveness
2013	Malaysian Health Technology Assessment (MaHTAS)	Ultraviolet Germicidal Irradiation (UVGI) indoor purifier – an update
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tenofovir disoproxil fumarate (Viread®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Extracorporeal circuit for patients undergoing hemodialysis: safety
2013	HAYES, Inc.	Umbilical cord blood stem cell transplantation for hematological cancers and nonmalignant disorders in children
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group care for chronic disease management: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Systematic review on needs for medical devices for older people
2013	National Institute for Health and Care Excellence (NICE)	EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing. NICE medical technologies guidance 12
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Adalimumab (Humira®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Peripherally inserted central catheter-associated mast cell activation syndrome: clinical evidence
2013	HAYES, Inc.	Vagus nerve stimulation for depression
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Needle or open fasciotomy for dupuytren
2013	Haute Autorite de sante (HAS)	[Laser treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia]
2013	Malaysian Health Technology Assessment (MaHTAS)	Symptoms checker
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Nepafenac (Nevanac®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mold prevention for hospital bed mattresses: clinical effectiveness and guidelines
2013	HAYES, Inc.	Video Electrencephalogram (VEEG) for the diagnosis and treatment of epilepsy in children
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Medication assessment alerts for in-hospital medication management: clinical evidence and guidelines
2013	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Breast prosthesis implantation for reconstructive and cosmetic surgery: a rapid review
2013	Haute Autorite de sante (HAS)	[Clinical utility of the measurement of vitamin D]
2013	Institute of Health Economics (IHE)	Total prosthetic replacement of the temporomandibular joint: a rapid evidence assessment and economic analysis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Supraglottic airway devices in out-of-hospital settings: clinical evidence and guidelines
2013	HAYES, Inc.	Video Electroencephalogram (VEEG) for diagnosis and management of epilepsy in adults
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Peer support for diabetes, heart disease and HIV/AIDS: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013	Haute Autorite de sante (HAS)	[Bone substitutes]
2013	National Institute for Health and Care Excellence (NICE)	Ambu aScope4 Broncho for use in unexpected difficult airways. NICE medical technologies guidance 14
2013	NIHR Health Technology Assessment programme	Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer. A systematic review and overview of reviews
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pediatric stretchers and stretcher cribs: safety and guidelines
2013	HAYES, Inc.	Yoga for chronic low back pain
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pain neurophysiology education for the management of persistent pain: clinical evidence and guidelines
2013	Haute Autorite de sante (HAS)	[Bypass prostheses]
2013	Malaysian Health Technology Assessment (MaHTAS)	QuantiFERON® -TB Gold
2013	Agency for Healthcare Research and Quality (AHRQ)	Assessment on implantable defibrillators and the evidence for primary prevention of sudden cardiac death
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The use of restraints during acute mental health interventions: a review of the clinical evidence and guidelines
2013	HAYES, Inc.	Immunoglobulin gene testing in b-cell lymphoma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Negative pressure wound therapy for the management of high risk surgical incisions or high risk patients: clinical effectiveness, cost-effectiveness, and guidelines
2013	Malaysian Health Technology Assessment (MaHTAS)	Platelet rich plasma for treatment of osteoarthritis
2013	NIHR Health Technology Assessment programme	HESTER study: Has electrical sinus translated into effective remodelling?
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Updated reports and recommendations on second- and third-line therapies for type 2 diabetes
2013	HAYES, Inc.	MammaPrint for prognosis of breast cancer recurrence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Multi-dose contrast media for patients undergoing computed tomography: clinical benefits, harms, and guidelines
2013	National Institute for Health and Care Excellence (NICE)	Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract. NICE technology appraisal guidance 272
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cefazolin for preoperative prophylaxis in overweight adults having any type of surgery: clinical effectiveness and guidelines
2013	HAYES, Inc.	Phenylalanine hydroxylase (PAH) deficiency (including phenylketonuria [PKU])
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Follow-up imaging for simple adnexal cysts: clinical evidence, cost-effectiveness and guidelines
2013	Haute Autorite de sante (HAS)	[Spinal implants (interbody cage, interspinous process spacer, spacer, lumbosacral support implant)]
2013	Malaysian Health Technology Assessment (MaHTAS)	Autologous peripheral blood stem cells for articular cartilage repair
2013	National Institute for Health and Care Excellence (NICE)	Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal). NICE technology appraisal guidance 273
2013	NIHR Health Technology Assessment programme	The clinical and cost-effectiveness of different treatment pathways for neuropathic pain (NP)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Indigenous knowledge for smoking cessation: benefits and effectiveness
2013	HAYES, Inc.	PLP1-related disorders (including pelizaeus-merzbacher disease [PMD])
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Central venous catheter removal
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ultrasound versus computed tomography for children with suspected appendicitis: clinical evidence, cost-effectiveness, and guidelines
2013	Malaysian Health Technology Assessment (MaHTAS)	NH2 Drug Lab (DRUGKOP)
2013	National Institute for Health and Care Excellence (NICE)	Ranibizumab for treating diabetic macular oedema. NICE technology appraisal guidance 274
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening and diagnostic tools for autism spectrum disorder in children: a review of guidelines
2013	HAYES, Inc.	Prolaris test for prediction of prostate cancer progression
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Delivery of podiatry care for adults with diabetes or chronic foot conditions: a review of the clinical effectiveness
2013	Malaysian Health Technology Assessment (MaHTAS)	Mobile phone with portable electrocardiogram (ECG) device